Drug intelligence / Profile preview

aceglutamide

Development stage
Unknown
Lead developer
Buchang Pharmaceuticals
Modality
Small Molecules, Peptides
Administration
Oral, Intravenous, Intramuscular
01

Overview

Aceglutamide is an acetylated derivative of the amino acid L-glutamine that functions as a neuroprotective agent, psychostimulant, and mucosal protective agent. It is primarily utilized in the treatment of cerebrovascular and neurological conditions, including ischemic stroke, traumatic brain injury, and cognitive impairment. Aceglutamide effectively crosses the blood-brain barrier, where it acts as a precursor to the neurotransmitters glutamate and GABA. Its neuroprotective mechanism involves the activation of the **Akt/Bcl-2 signaling pathway** and the inhibition of the pro-apoptotic factor **TRAF1**. Additionally, it exhibits potent antioxidant properties by enhancing the **Nrf2**, glutathione (GSH), and thioredoxin (Trx) systems, and exerts anti-inflammatory effects by suppressing **NF-κB** translocation and the production of proinflammatory cytokines. In clinical practice, particularly in China, it is frequently administered as a component of **Guhong Injection**, a combination therapy with safflower extract (*Carthamus tinctorius*). Its aluminum salt, aceglutamide aluminum, is also used orally to treat peptic ulcers by providing mucosal protection.

Brand names
GuhongGlumal
Other names
N-acetyl-L-glutamineacetylglutamineN-acetylglutamineACGAGaceglutamide aluminumN-acetyl-L-glutamine aluminum salt
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)TRAF1 (TNF receptor-associated factor 1)NF-κBBCL-2 (BCL-2 family)

Beyond the preview

Go deeper on aceglutamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aceglutamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call